$3.83-5.20%
2026-10-06 close · prelimImmuneering Class A's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$64M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy
Immuneering Class A's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$64M.